The Fall ENGOT meeting took place in Amsterdam at the end of September last. CEEGOG was represented by its Chairman Prof. David Cibula and the administrative Manager Mrs. Ivana Nohová.

On the first day, the meeting of Operationals and also the strategic meeting were held. At the meeting of the Operationals, we discussed group experience with the CTIS and regulatory authority surveillance which is one of the Sponsor´s responsibilities for each trial. The main discussion aimed at the feedback from the Working groups as defined by the ENGOT Strategic Group last year. As a reminder, those groups deal with the effective coordination and communication, with academic studies promotion, sustainabiility and early development of new drugs, mentoring groups and young investigators, the ENGOT database and relationship with non-European groups. The Update has also been provided by the Contract working group and Budgeting working group.  

The assembly meeting was held on September 27, 2024. From the CEEGOG studies, the update on the SENTIX study was provided.Twelve new trial proposals are currently developing, and each of them is now in a different phase of negotiation with the Pharmaceutical companies and of trial preparation. The CEEGOG members will be informed on each trial once the trial is prepared for country and site selection.  Among the new trial ideas, which were introduced at the ENGOT meeting, it is worth mentioning that CEEGOG has been appointed as the Lead Engot group for the commercial trial entitled AZALEA and sponsored by Abbvie. We look forward to cooperating on this exciting study!